Peresolimab, a humanized immunoglobulin G1 monoclonal antibody designed to stimulate the endogenous programmed cell death protein 1 (PD-1) inhibitory pathway, is efficacious for patients with rheumatoid arthritis, according ...
May 18, 2023
0
18
For patients with symptomatic, radiographic, moderate-to-severe osteoarthritis or osteonecrosis of the hip or knee, total joint arthroplasty (TJA) should not be delayed in order to pursue additional nonoperative treatments, ...
Apr 7, 2023
0
2
The American College of Rheumatology (ACR) and the American Association of Hip and Knee Surgeons (AAHKS) have released a summary of its new guideline titled "the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients ...
Mar 14, 2023
0
2
Results from a recent clinical trial published by Wiley in Arthritis & Rheumatology demonstrate that patients with knee osteoarthritis experience short term pain relief from genicular nerve blocks—or locally injected anesthetics ...
Nov 12, 2022
0
15
Tyrosine kinases are enzymes that play central roles in signaling by cytokines involved in the pathogenesis of autoimmune diseases, including lupus. A recent phase 2 clinical trial published in Arthritis & Rheumatology has ...
Nov 12, 2022
0
5
New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found a greater number of preterm births in unvaccinated versus fully vaccinated pregnant patients with rheumatic ...
Nov 8, 2022
0
10
Research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, described a novel program that offers rheumatoid arthritis (RA) training to primary care providers in the Navajo ...
Nov 8, 2022
0
0
New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found no clear association between immunosuppressive or anti-fibrotic medications and worsening gastrointestinal ...
Nov 8, 2022
0
2
New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, shows that spine disease, once considered a rarity in chronic recurrent multifocal osteomyelitis, affects as ...
Nov 8, 2022
0
5
New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, demonstrated that withholding mycophenolate mofetil for at least 10 days significantly increased antibody response ...
Nov 8, 2022
0
2
